Skip to main content
SpringerLink
Log in

Chelation of chromium(VI) by combining deferasirox and deferiprone in rats

  • Published:
BioMetals Aims and scope Submit manuscript

Abstract

The present research is aimed to characterize the potential efficiency of two chelators after chromium(VI) administration for 60 days following two doses of 15 and 30 mg/kg chromium(VI) per body weight daily to male rats. However, the hypothesis that the two chelators might be more efficient as combined therapy than as single therapy in removing chromium(VI) from rat organs was considered. In this way, two known chelators deferasirox and deferiprone were chosen and given orally as a single or combined therapy for a period of 1 week. Chromium(VI) and iron concentrations in tissues were determined by flame atomic absorption spectroscopy. The combined chelation therapy results show that deferasirox and deferiprone are able to remove chromium(VI) ions from various tissues while iron concentration returned to normal levels and symptoms also decreased.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1

Similar content being viewed by others

References

  • Agency for Toxic Substances and Diseases Registry (ATSDR) (1998) Toxicological profile for chromium. Public Health Service. US Department of Health and Human Services, Atlanta

  • Amiri A, Fatemi SJ, Fatemi SN (2007) Removal of thallium by combining desferrioxamine and deferiprone chelators in rats. Biometals 20:159–163

    Article  CAS  PubMed  Google Scholar 

  • Bagchi D, Stohs SJ, Downs BW, Bagchi M, Preuss HG (2002) Cytotoxicity and oxidative mechanisms of different forms of chromium. Toxicology 180:5–22

    Article  CAS  PubMed  Google Scholar 

  • Cappellini MD (2008) Long-term efficacy and safety of deferasirox. Blood Rev 2:35–41

    Article  Google Scholar 

  • Clarke ET, Martell AE (1992) Stabilities of 1, 2-dimethyl-3-hydroxypyrid-4-one chelates of divalent and trivalent metal ions. Inorg Chim Acta 19:57–63

    Article  Google Scholar 

  • Codd R, Dillon CT, Levina A, Lay PA (2001) Studies on the genotoxicity of chromium: from the test tube to the cell. Coord Chem Rev 216–217:537–582

    Article  Google Scholar 

  • Evans RW, Kong X, Hider RC (2012) Iron mobilization from transferrin by therapeutic iron chelating agents. Biochim Biophys Acta 1820:282–290

    Article  CAS  PubMed  Google Scholar 

  • Fatemi SJ, Amiri A, Bazargan MH, Tubafard S, Fatemi SN (2007) Clinical evaluation of desferrioxamine (DFO) for removal of thallium ions in rats. Int J Artif Organs 30:902–905

    CAS  PubMed  Google Scholar 

  • Fatemi SJ, Tubafard S, Nadi B (2009) Evaluation of the effect of cadmium on rat organs and investigation of diethyl carbamate as an oral drug in treatment of cadmium toxicity. Med Chem Res 18:179–186

    Article  Google Scholar 

  • Flora SJS, Bhattacharyan R, Vijayaraghavan R (1995) Combined therapeutic potential of meso dimercaptosuccinic acid and calcium edentate on the mobilization and distribution of lead in experimental lead intoxication in rats. Fundam Appl Toxicol 25:233–240

    Article  CAS  PubMed  Google Scholar 

  • Galanello R, Agus A, Campus S, Danjou F, Giardina PJ, Grady RW (2010) Combined iron chelation therapy. Ann N Y Acad Sci 1202:79–86

    Article  CAS  PubMed  Google Scholar 

  • Glickstein H, BenEl R, Link G, Breuer W, Konijn AM, Hershko C, Nick H, Cabantchik ZI (2006) Action of chelators in iron-loaded cardiac cells: accessibility to intracellular labile iron and functional consequences. Blood 108:3195–3203

    Article  CAS  PubMed  Google Scholar 

  • Gomez W, Esparza JL, Domingo JL, Singha PK, Jones MM (1988) Comparative aluminium mobilizing action of desferrioxamine and four 3-hydroxypyrid-4-ones in aluminium-loaded rats. Toxicology 130:175–181

    Article  Google Scholar 

  • Gyparaki M, Porter JB, Hirani S, Streater M, Hider RC, Huehns ER (1987) In vivo evaluation of hydroxypyridone iron chelators in a mouse model. Acta Haematol 78:217–221

    Article  CAS  PubMed  Google Scholar 

  • Heinz U, Hegetschweiler K, Acklin P, Faller B, Lattmann R, Schnebli HP (1999) 4-[3,5-Bis (2-hydroxyphenyl)-1,2,4-triazol-1-yl]-benzoic acid: a novel, efficient and selective iron (iii) complexing agent. Angew Chem Int Edit 38:2568–2571

    Article  CAS  Google Scholar 

  • Hershko C, Konijn AM, Nick HP, Breuer W, Cabantchik ZI, Link G (2001) ICL670A: a new synthetic oral chelator: evaluation in hypertransfused rats with selective radioiron probes of hepatocellular and reticuloendothelial iron stores and in iron-loaded rat heart cells in culture. Blood 97:1115–1122

    Article  CAS  PubMed  Google Scholar 

  • Hider RC, Kontoghiorghes G, Silver J (1984) Pharmaceutical compositions. GB patent 2118176 A

  • Kaur G, Srivastava UC, Dwivedi RS, Srivastava RC (1984) Influence of polyaminocarboxylic acids on the removal of manganese-54 from the body organs of sham-operated and partially hepatectomized rats. Toxicol Lett 22:1–6

    Article  CAS  PubMed  Google Scholar 

  • Kimbrough DE, Cohen Y, Winer AM (1999) A critical assessment of chromium in the environment. Crit Rev Environ Sci Technol 29:1–46

    Article  CAS  Google Scholar 

  • Kontoghiorghes GJ, Aldouri MA, Hoffbrand AV, Barr J, Wonke B, Kourouclaris T, Sheppard L (1987) Effective chelation of iron in beta thalassaemia with the oral chelator 1,2-dimethyl-3-hydroxypyrid-4-one. Br Med J 295:1509–1512

    Article  CAS  Google Scholar 

  • Ma Y, Zhou T, Kong X, Hider RC (2012) Chelating agents for the treatment of systemic iron overload. Curr Med Chem 19:2816–2827

    Article  CAS  PubMed  Google Scholar 

  • Neufeld EJ (2006) Oral chelators deferasirox and deferiprone for transfusional iron overload in thalassemia major: new data, new questions. Blood 107(9):3436–3441

    Article  CAS  PubMed  Google Scholar 

  • Nisbet-Brown E, Olivieri NF, Giardina PJ, Grady RW, Neufeld EJ, Sechaud R (2003) Effectiveness and safety of ICL670 in iron-loaded patients with thalassaemia: a placebo-controlled, dose-escalation trial. Lancet 361:1597–1602

    Article  CAS  PubMed  Google Scholar 

  • O’Brien TJ, Ceryak S, Patierno SR (2003) Complexities of chromium carcinogenesis: role of cellular response, repair and recovery mechanisms. Mutat Res 533:3–36

    Article  PubMed  Google Scholar 

  • Shokooh Saljooghi A, Fatemi SJ (2010) Clinical evaluation of deferasirox for removal of cadmium ions in rat. Biometals 23:707–712

    Article  Google Scholar 

  • Steinhauser S, Heinz U, Bartholoma M, Weyhermu¨ller T, Nick H, Hegetschweiler K (2004) Complex formation of ICL670 and related ligands with Fe(III) and Fe(II). Eur J Inorg Chem 21:4177–4192

    Article  Google Scholar 

  • Tubafard S, Fatemi SJ (2008) Chelation of bismuth by combining desferrioxamine and deferiprone in rats. Toxicol Ind Health 24:235–240

    Article  CAS  PubMed  Google Scholar 

  • Voskaridou E, Christoulas D, Terpos E (2011) Successful chelation therapy with the combination of deferasirox and deferiprone in a patient with thalassaemia major and persisting severe iron overload after single-agent chelation therapies. Br J Haematol 154:654–656

    Article  PubMed  Google Scholar 

  • Yang LPH, Keam SJ, Keating GM (2007) Deferasirox: a review of its use in the management of transfusional chronic iron overload. Drugs 67:2211–2230

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Chemistry Department, Shahid Bahonar University of Kerman, 22 Bahman Blvd, PO BOX 76961, Kerman, Iran

    Marzieh Iranmanesh, S. Jamil A. Fatemi, Roza Ebrahimpour & Faezeh Dahooee Balooch

Authors
  1. Marzieh Iranmanesh
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. S. Jamil A. Fatemi
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Roza Ebrahimpour
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Faezeh Dahooee Balooch
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Marzieh Iranmanesh.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Iranmanesh, M., Fatemi, S.J.A., Ebrahimpour, R. et al. Chelation of chromium(VI) by combining deferasirox and deferiprone in rats. Biometals 26, 465–471 (2013). https://doi.org/10.1007/s10534-013-9631-5

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10534-013-9631-5

Keywords

Search

Navigation